Roubaix Capital, LLC

13F Filings History

Latest 13F report
Q2 2025 - Aug 13, 2025
Value $
$208M
Signature - Title
Tara Mcclanahan - COMPLIANCE CONSULTANT
Location
Denver, CO
Summary
This page shows a list of all the recent 13F filings made by Roubaix Capital, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Roubaix Capital, LLC reported 51 stock holdings with total value $208M as of Q2 2025. Top holdings included TATT, GTLS, GENI, NPKI, and SARO.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q2 2025 51 $208M +$93.8M -$101M -$7.01M TATT, GTLS, GENI, NPKI, SARO 13F-HR 8/13/2025, 11:57 AM
Q1 2025 50 $192M +$115M -$118M -$2.14M SARO, PKE, GENI, ATEX, COLD 13F-HR 5/13/2025, 03:52 PM
Q4 2024 47 $209M +$109M -$91.3M +$17.9M FTAI, TLN, BELFB, NPKI, PKE 13F-HR 2/13/2025, 01:35 PM
Q3 2024 47 $181M +$87M -$70.2M +$16.8M TLN, FTAI, B, LSCC, OEC 13F-HR 10/25/2024, 04:30 PM
Q2 2024 45 $158M +$55.4M -$63.4M -$8.1M B, FTAI, ATEX, PKE, NR 13F-HR 8/2/2024, 01:35 PM
Q1 2024 47 $158M +$64.4M -$59.1M +$5.29M FTAI, PKE, B, CRS, ATEX Restatement 8/1/2024, 12:16 PM
Q4 2023 44 $143M +$60.6M -$63.4M -$2.8M SHC, GENI, FTAI, MKSI, ATEX Restatement 8/1/2024, 12:37 PM
Q3 2023 42 $136M +$54.5M -$53.8M +$694K PKE, CRS, SHC, ATEX, GENI Restatement 8/1/2024, 12:26 PM
Q2 2023 40 $136M +$59M -$9.7M +$49.3M FTAI, SHC, PKE, ATEX, CRS 13F-HR 7/26/2023, 03:14 PM
Q1 2023 43 $131M +$54.4M -$16.8M +$37.6M OEC, FTAI, NSSC, PKE, ASLE 13F-HR 5/9/2023, 09:24 AM
Q4 2022 45 $124M +$65.1M -$9.09M +$56M NSSC, PKE, ATEX, OEC, GFL 13F-HR 2/6/2023, 10:21 AM
Q3 2022 41 $112M +$48.1M -$13.1M +$35M NSSC, PKE, ATEX, CCCS, NEOG 13F-HR 10/20/2022, 06:52 PM
Q2 2022 38 $116M +$43.9M -$16.9M +$27M NSSC, STAA, PKE, CYRX, OEC 13F-HR 8/5/2022, 02:59 PM
Q1 2022 41 $143M +$71M -$14.6M +$56.4M ATEX, NSSC, OEC, CYRX, MTRN 13F-HR 4/18/2022, 06:41 PM
Q4 2021 42 $164M +$75.5M -$17M +$58.5M ATEX, THRM, TMCI, MTRN, TNL 13F-HR 1/28/2022, 10:51 AM
Q3 2021 41 $153M +$63.5M -$69.3M -$5.71M ATEX, MEC, TNL, CEVA, ROG 13F-HR 10/18/2021, 02:18 PM
Q2 2021 42 $160M +$53.5M -$51.9M +$1.52M ATEX, KRMD, MOD, VICR, CEVA 13F-HR 7/22/2021, 03:34 PM
Q1 2021 51 $148M +$86.7M -$80.6M +$6.16M ATEX, IMMR, QADA, ROG, DESP 13F-HR 4/29/2021, 04:15 PM
Q4 2020 50 $130M +$63.6M -$9.06M +$54.6M ATEX, RAVN, TMDX, SRI, WCC 13F-HR 2/10/2021, 06:59 PM
Q3 2020 54 $84.8M +$43.7M -$3.39M +$40.3M OEC, AGYS, ROG, IIVI, GOOS 13F-HR 11/3/2020, 01:44 PM
Q2 2020 49 $75.3M +$43.2M -$9.67M +$33.6M TMDX, PGNY, IIVI, ATEX, OEC 13F-HR 7/28/2020, 04:09 PM
Q1 2020 46 $65.5M +$30.8M -$12.7M +$18.1M PKE, ATSG, TMDX, CEVA, COLD 13F-HR 4/15/2020, 11:01 AM
Q4 2019 36 $104M +$46.5M -$16.2M +$30.3M PKE, ATEX, TMDX, ROG, NVGS 13F-HR 1/15/2020, 02:49 PM
Q3 2019 33 $110M +$54.5M -$7.72M +$46.7M PKE, CUB, ATSG, TMDX, ROG 13F-HR 10/8/2019, 12:46 PM
Q2 2019 33 $120M +$79.1M -$4.33M +$74.7M PSN, CUB, BIO, PKE, COLD 13F-HR 7/30/2019, 12:10 PM
Q1 2019 38 $101M FORR, SCL, PEGA, MMSI, MEI 13F-HR 4/2/2019, 01:34 PM